Reply to ‘Factors influencing the outcome of polypoidal choroidal vasculopathy following combined treatment with photodynamic therapy and intravitreal ranibizumab'

類似資料

• Factors influencing the outcome of polypoidal choroidal vasculopathy following combined treatment with photodynamic therapy and intravitreal ranibizumab
  著者:: Tan, C S, 等
  出版事項: (2015)
• Intravitreal ranibizumab injection combined with photodynamic therapy for polypoidal choroidal vasculopathy
  著者:: Li, Jia, 等
  出版事項: (2018)
• Outcome of polypoidal choroidal vasculopathy at 1 year by combined therapy of photodynamic therapy with ranibizumab and predictive factors governing the outcome
  著者:: Ho, M, 等
  出版事項: (2014)
• Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy
  著者:: Wataru, Kikushima, 等
  出版事項: (2020)
• Two-year follow-up of ranibizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy
  著者:: Nemoto, Rei, 等
  出版事項: (2012)